146 related articles for article (PubMed ID: 8242591)
1. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization.
Nylund SJ; Verbeek W; Larramendy ML; Ruutu T; Heinonen K; Hallman H; Knuutila S
Cancer Genet Cytogenet; 1993 Oct; 70(2):120-4. PubMed ID: 8242591
[TBL] [Abstract][Full Text] [Related]
2. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.
Kibbelaar RE; van Kamp H; Dreef EJ; de Groot-Swings G; Kluin-Nelemans JC; Beverstock GC; Fibbe WE; Kluin PM
Blood; 1992 Apr; 79(7):1823-8. PubMed ID: 1558974
[TBL] [Abstract][Full Text] [Related]
3. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
Saitoh K; Miura I; Takahashi N; Miura AB
Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
[TBL] [Abstract][Full Text] [Related]
5. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH).
Han K; Lee W; Harris CP; Kim W; Shim S; Meisner LF
Leukemia; 1994 Jan; 8(1):81-6. PubMed ID: 8289503
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies.
Fagioli F; Cuneo A; Bardi A; Carli MG; Bigoni R; Balsamo R; Previati R; Pazzi I; Roberti G; Rigolin GM
Cancer Genet Cytogenet; 1995 Jul; 82(2):116-22. PubMed ID: 7664240
[TBL] [Abstract][Full Text] [Related]
7. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes.
Soenen V; Fenaux P; Flactif M; Lepelley P; Lai JL; Cosson A; Preudhomme C
Br J Haematol; 1995 Jul; 90(3):701-6. PubMed ID: 7647013
[TBL] [Abstract][Full Text] [Related]
8. Clonal CD5-positive B lymphocytes in myelodysplastic syndrome with systemic vasculitis and trisomy 8.
Billström R; Johansson B; Strömbeck B; el-Rifai W; Larramendy M; Olofsson T; Mitelman F; Knuutila S
Ann Hematol; 1997 Jan; 74(1):37-40. PubMed ID: 9031614
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic clonality analysis in myelodysplastic syndrome: monosomy 7 can be demonstrated in the myeloid and in the lymphoid lineage.
van Lom K; Hagemeijer A; Smit E; Hählen K; Groeneveld K; Löwenberg B
Leukemia; 1995 Nov; 9(11):1818-21. PubMed ID: 7475268
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
Anastasi J; Feng J; Le Beau MM; Larson RA; Rowley JD; Vardiman JW
Blood; 1993 Mar; 81(6):1580-5. PubMed ID: 8453104
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and experimental study of 38 cases with trisomy 8].
Xu WL; Jin J; Chen ZM; Lou JY; Yu YB
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):528-31. PubMed ID: 14669224
[TBL] [Abstract][Full Text] [Related]
12. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
13. [Detection of trisomy 8 with interphase fluorescence in situ hybridization in myelodysplastic syndromes].
Li J; Pan J; Xue Y; Wu C; Xie X; Guo Y; Ruan C
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):179-81. PubMed ID: 11876976
[TBL] [Abstract][Full Text] [Related]
14. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome.
Zipursky A; Wang H; Brown EJ; Squire J
Blood; 1994 Oct; 84(7):2278-82. PubMed ID: 7919346
[TBL] [Abstract][Full Text] [Related]
15. Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization.
Abruzzese E; Buss D; Rainer R; Rao PN; Pettenati MJ
Leuk Res; 1996 Jul; 20(7):551-7. PubMed ID: 8795688
[TBL] [Abstract][Full Text] [Related]
16. [Detection of trisomy 8 and monosomy 7 in chronic granulocytic leukemia and myelodysplastic syndrome by cytogenetic analysis and fluorescence in situ hybridization].
Szabó Gabriella P; Balogh E; Jakab Z; Germán P; Bodnár F; Kiss A; Telek B; Oláh E
Orv Hetil; 2002 Dec; 143(50):2775-9. PubMed ID: 12583317
[TBL] [Abstract][Full Text] [Related]
17. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting.
Miura I; Kobayashi Y; Takahashi N; Saitoh K; Miura AB
Br J Haematol; 2000 Sep; 110(4):876-9. PubMed ID: 11054073
[TBL] [Abstract][Full Text] [Related]
18. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of centromeric fusion in 7p/1q translocation associated with myelodysplastic syndrome.
Hoo JJ; Szego K; Jones B
Cancer Genet Cytogenet; 1992 Dec; 64(2):186-8. PubMed ID: 1486571
[TBL] [Abstract][Full Text] [Related]
20. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
